A Prospective, Multi-Center, Longitudinal Study of Dynamic Quantification of Social-Visual Engagement For Treatment Monitoring in Children with Autism Spectrum Disorder
Site Coordinator
conducting periodic in-house audits. These practices alongside enhancing participant comfort and compliance during visits by adapting to differing behavioral needs and developing personalized communication techniques resulted in a significant increase in data quality.
Seven study visits occurred over a six month period, consisting of the administration of the Earlipoint eye-tracking assessment, an Autism Diagnostic Observation Schedule (ADOS-2), and cognitive assessments. Depending on the age and verbal ability of the participant either the Mullen Scales of Early Learning or the Differential Ability Scales (DAS-II) was administered. Alongside this, we conducted the Vineland Adaptive Behavior Scales Interviews with the subjects parents. Ultimately, our sites (Cortica) were the first to reach their enrollment capacity for this study.
This trial aims to assess changes in key developmental milestones over time using the Earlipoint system, a novel FDA-authorized eye-tracking device that measures a child’s individual attention to social situations.
As a site coordinator, I managed the trials daily operations from recruiting, enrolling, and scheduling, to running visits for 70+ participants and managing data. To provide greater accessibility we offered a novel approach of allowing in-home, as well as in-clinic visits. With high interest in participation and the time-intensive responsibilities of the trial, I pioneered comprehensive organizational systems to accommodate the emerging demands and ensure compliance. To monitor our consistency across administrators and guarantee prestine documentation of data, I also established the practice of